These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31739549)

  • 1. Immunization with the HisAK70 DNA Vaccine Induces Resistance against
    Martínez-Rodrigo A; S Dias D; Ribeiro PAF; Roatt BM; Mas A; Carrión J; Coelho EAF; Domínguez-Bernal G
    Vaccines (Basel); 2019 Nov; 7(4):. PubMed ID: 31739549
    [No Abstract]   [Full Text] [Related]  

  • 2. Alternative strategy for visceral leishmaniosis control: HisAK70-Salmonella Choleraesuis-pulsed dendritic cells.
    Domínguez-Bernal G; Martínez-Rodrigo A; Mas A; Blanco MM; Orden JA; De La Fuente R; Carrión J
    Comp Immunol Microbiol Infect Dis; 2017 Oct; 54():13-19. PubMed ID: 28915996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HisAK70: progress towards a vaccine against different forms of leishmaniosis.
    Domínguez-Bernal G; Horcajo P; Orden JA; Ruiz-Santa-Quiteria JA; De La Fuente R; Ordóñez-Gutiérrez L; Martínez-Rodrigo A; Mas A; Carrión J
    Parasit Vectors; 2015 Dec; 8():629. PubMed ID: 26653170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope Selection for Fighting Visceral Leishmaniosis: Not All Peptides Function the Same Way.
    Martínez-Rodrigo A; Mas A; Álvarez-Campos D; Orden JA; Domínguez-Bernal G; Carrión J
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32630347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inoculation of the
    Soto M; Ramírez L; Solana JC; Cook ECL; Hernández-García E; Requena JM; Iborra S
    Microorganisms; 2021 Feb; 9(2):. PubMed ID: 33673117
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania chagasi and Leishmania amazonensis challenge.
    Chávez-Fumagalli MA; Costa MA; Oliveira DM; Ramírez L; Costa LE; Duarte MC; Martins VT; Oliveira JS; Olortegi CC; Bonay P; Alonso C; Tavares CA; Soto M; Coelho EA
    Microbes Infect; 2010 Nov; 12(12-13):967-77. PubMed ID: 20601076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strength and medium-term impact of HisAK70 immunization in dogs: Vaccine safety and biomarkers of effectiveness for ex vivo Leishmania infantum infection.
    Martínez-Rodrigo A; Mas A; Fernández-Cotrina J; Belinchón-Lorenzo S; Orden JA; Arias P; de la Fuente R; Carrión J; Domínguez-Bernal G
    Comp Immunol Microbiol Infect Dis; 2019 Aug; 65():137-143. PubMed ID: 31300103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of Experimental Dogs With Salivary Proteins From
    Abbehusen MMC; Cunha J; Suarez MS; Teixeira C; Almeida VDA; Pereira LDS; Bordoni M; Gil-Santana L; Solcà MDS; Fraga DBM; Fischer L; Bozza PT; Veras PST; Valenzuela JG; Kamhawi S; Andrade BB; Brodskyn CI
    Front Immunol; 2018; 9():2558. PubMed ID: 30519235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protective efficacy of Leishmania infantum LiHyD protein against tegumentary leishmaniasis caused by Leishmania major and Leishmania braziliensis species.
    Lage DP; Martins VT; Duarte MC; Costa LE; Tavares GSV; Ramos FF; Chávez-Fumagalli MA; Menezes-Souza D; Roatt BM; Tavares CAP; Coelho EAF
    Acta Trop; 2016 Jun; 158():220-230. PubMed ID: 26976272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vaccine composed of a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection.
    Duarte MC; Lage DP; Martins VT; Costa LE; Carvalho AMRS; Ludolf F; Santos TTO; Vale DL; Roatt BM; Menezes-Souza D; Fernandes AP; Tavares CAP; Coelho EAF
    Immunobiology; 2017 Feb; 222(2):251-260. PubMed ID: 27693018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immune responses and protection induced by A2 and nucleoside hydrolase (NH) DNA vaccines against Leishmania chagasi and Leishmania amazonensis experimental infections.
    Zanin FH; Coelho EA; Tavares CA; Marques-da-Silva EA; Silva Costa MM; Rezende SA; Gazzinelli RT; Fernandes AP
    Microbes Infect; 2007 Jul; 9(9):1070-7. PubMed ID: 17644455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
    Cargnelutti DE; Salomón MC; Celedon V; García Bustos MF; Morea G; Cuello-Carrión FD; Scodeller EA
    J Microbiol Immunol Infect; 2016 Feb; 49(1):24-32. PubMed ID: 24662018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant fusion protein displaying murine and human MHC class I- and II-specific epitopes protects against Leishmania amazonensis infection.
    Martins VT; Lage DP; Duarte MC; Carvalho AM; Costa LE; Mendes TA; Vale DL; Menezes-Souza D; Roatt BM; Tavares CA; Soto M; Coelho EA
    Cell Immunol; 2017 Mar; 313():32-42. PubMed ID: 28049560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phage-fused epitopes from Leishmania infantum used as immunogenic vaccines confer partial protection against Leishmania amazonensis infection.
    Costa LE; Chávez-Fumagalli MA; Martins VT; Duarte MC; Lage DP; Lima MI; Pereira NC; Soto M; Tavares CA; Goulart LR; Coelho EA
    Parasitology; 2015 Sep; 142(10):1335-47. PubMed ID: 26099574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
    Sanchez MV; Eliçabe RJ; Di Genaro MS; Germanó MJ; Gea S; García Bustos MF; Salomón MC; Scodeller EA; Cargnelutti DE
    Parasite Immunol; 2017 Nov; 39(11):. PubMed ID: 28901553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of iron superoxide dismutase-encoding DNA vaccine on the evolution of the Leishmania amazonensis experimental infection.
    Campos BL; Silva TN; Ribeiro SP; Carvalho KI; Kallás EG; Laurenti MD; Passero LF
    Parasite Immunol; 2015 Aug; 37(8):407-16. PubMed ID: 26040192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
    Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
    Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.